CRISPR Therapeutics AG (CRSP) Institutional Ownership and Insiders Activity

CRISPR Therapeutics AG (CRSP) is widely held by institutional investors, with 507 firms reporting positions valued at approximately $5.45B based on SEC Form 13F filings for the quarter ended June 30, 2026.

Banque Cantonale Vaudoise is the largest disclosed holder, reporting approximately $1.31B in CRSP holdings in its latest filing.

Recent insider activity includes 12 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.